Peter Marks says the new health secretary’s team wants to show vaccines aren’t safe while promoting dangerous and unproven ...

Key Takeaways Moderna and other vaccine stocks fell Monday after the Food and Drug Administration's vaccine chief, Peter ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’ crosshairs following the resignation of Dr.

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

The health agency’s top immunization official announced the move Monday in protest, citing Secretary Kennedy’s ‘misinformation and lies.’ Stocks of major vaccine makers dropped on Monday after the ...

Robert F. Kennedy Jr. is set to significantly cut the size of HHS, reshaping the nation’s health agencies and closing ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Robert F. Kennedy Jr.'s confirmation as Secretary of Health and Human Services has raised questions about future healthcare policy. However, Pfizer's foundation remains solid, based on strong cash ...